Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Emilie Bousquet"'
Autor:
Nour Sfeir, Marilyn Kajdan, Stéphan Jalaguier, Sandrine Bonnet, Catherine Teyssier, Samuel Pyrdziak, Rong Yuan, Emilie Bousquet, Antonio Maraver, Florence Bernex, Nelly Pirot, Florence Boissière‐Michot, Audrey Castet‐Nicolas, Marion Lapierre, Vincent Cavaillès
Publikováno v:
Molecular Oncology, Vol 18, Iss 6, Pp 1510-1530 (2024)
The transcription factor receptor‐interacting protein 140 (RIP140) regulates intestinal homeostasis and tumorigenesis through Wnt signaling. In this study, we investigated its effect on the Notch/HES1 signaling pathway. In colorectal cancer (CRC) c
Externí odkaz:
https://doaj.org/article/ef62a18970854d809d547ebde1121c5e
Autor:
Diala Kantar, Emilie Bousquet Mur, Maicol Mancini, Vera Slaninova, Yezza Ben Salah, Luca Costa, Elodie Forest, Patrice Lassus, Charles Géminard, Florence Boissière-Michot, Béatrice Orsetti, Charles Theillet, Jacques Colinge, Christine Benistant, Antonio Maraver, Lisa Heron-Milhavet, Alexandre Djiane
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-20 (2021)
Abstract Alterations to cell polarization or to intercellular junctions are often associated with epithelial cancer progression, including breast cancers (BCa). We show here that the loss of the junctional scaffold protein MAGI1 is associated with ba
Externí odkaz:
https://doaj.org/article/360a50e2dc1748519708e862bd828014
Autor:
Maicol Mancini, Hilah Gal, Nadège Gaborit, Luigi Mazzeo, Donatella Romaniello, Tomer Meir Salame, Moshit Lindzen, Georg Mahlknecht, Yehoshua Enuka, Dominick GA Burton, Lee Roth, Ashish Noronha, Ilaria Marrocco, Dan Adreka, Raya Eilam Altstadter, Emilie Bousquet, Julian Downward, Antonio Maraver, Valery Krizhanovsky, Yosef Yarden
Publikováno v:
EMBO Molecular Medicine, Vol 10, Iss 2, Pp 294-308 (2017)
Abstract Epidermal growth factor receptor (EGFR) mutations identify patients with lung cancer who derive benefit from kinase inhibitors. However, most patients eventually develop resistance, primarily due to the T790M second‐site mutation. Irrevers
Externí odkaz:
https://doaj.org/article/29209c6b4c714c0b85c5ff5816ce736b
Autor:
Olivier Calvayrac, Julien Mazières, Sarah Figarol, Claire Marty‐Detraves, Isabelle Raymond‐Letron, Emilie Bousquet, Magali Farella, Estelle Clermont‐Taranchon, Julie Milia, Isabelle Rouquette, Nicolas Guibert, Amélie Lusque, Jacques Cadranel, Nathalie Mathiot, Ariel Savina, Anne Pradines, Gilles Favre
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 2, Pp 238-250 (2016)
Abstract Although lung cancer patients harboring EGFR mutations benefit from treatment with EGFR‐tyrosine kinase inhibitors (EGFR‐TKI), most of them rapidly relapse. RHOB GTPase is a critical player in both lung carcinogenesis and the EGFR signal
Externí odkaz:
https://doaj.org/article/87c6a7f2a28d49bcac5ac6843c64f76e
Autor:
Nour Sfeir, Marilyn Kajdan, Stéphan Jalaguier, Sandrine Bonnet, Catherine Teyssier, Samuel Pyrdziak, Rong Yuan, Emilie Bousquet, Antonio Maraver, Florence Bernex, Nelly Pirot, Florence Boissiere, Audrey Castet-Nicolas, Marion Lapierre, Vincent Cavaillès
BackgroundThe transcription factor RIP140 (Receptor Interacting Protein of 140 kDa) regulates intestinal homeostasis and tumorigenesis through the Wnt signaling. In this study, we have investigated its effect on the Notch/HES1 signaling pathway.Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9561c756652b5986e557e1c6727f48fd
https://doi.org/10.1101/2023.05.13.539637
https://doi.org/10.1101/2023.05.13.539637
Autor:
Julien Mazières, Gilles Favre, Julie Milia, Anne Casanova, Michèle Beau-Faller, Jacques Cadranel, Thomas Filleron, Valérie Lauwers-Cances, Emilie Bousquet, Isabelle Rouquette, Isabelle Raymond-Letron, Anne Pradines, Olivier Calvayrac
Legends to supplementary figures and tables. Contains detailed legends for supplementary figures S1-5 and supplementary tables 1 and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b70c0bff7acb4e547c5d6d968537663
https://doi.org/10.1158/1078-0432.22457441
https://doi.org/10.1158/1078-0432.22457441
Autor:
Julien Mazières, Gilles Favre, Julie Milia, Anne Casanova, Michèle Beau-Faller, Jacques Cadranel, Thomas Filleron, Valérie Lauwers-Cances, Emilie Bousquet, Isabelle Rouquette, Isabelle Raymond-Letron, Anne Pradines, Olivier Calvayrac
Supplementary Figure S4. Representative images of healthy lungs and lung tumors from EGFR/rhob mice stained with CD34 antibody, and corresponding quantification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b97263953eda4b06233869e94b3a0d7
https://doi.org/10.1158/1078-0432.22457426.v1
https://doi.org/10.1158/1078-0432.22457426.v1
Autor:
Julien Mazières, Gilles Favre, Julie Milia, Anne Casanova, Michèle Beau-Faller, Jacques Cadranel, Thomas Filleron, Valérie Lauwers-Cances, Emilie Bousquet, Isabelle Rouquette, Isabelle Raymond-Letron, Anne Pradines, Olivier Calvayrac
Supplemental Methods. This file contains additional methodology (Tumor/lung ratio quantification, Tumor size measurement and grading, CD34 staining and quantification, lung tissue processing for protein extraction for Western Blotting and PAS diastas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4333c6fffb1846d03e06a181061a24
https://doi.org/10.1158/1078-0432.22457438
https://doi.org/10.1158/1078-0432.22457438
Autor:
Julien Mazières, Gilles Favre, Julie Milia, Anne Casanova, Michèle Beau-Faller, Jacques Cadranel, Thomas Filleron, Valérie Lauwers-Cances, Emilie Bousquet, Isabelle Rouquette, Isabelle Raymond-Letron, Anne Pradines, Olivier Calvayrac
Supplementary Table S2. Kras and EGFR mutations and EGFR expression according to RhoB expression in tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ce7af7cf75c4205ed66aaa47abbbfd
https://doi.org/10.1158/1078-0432.22457417
https://doi.org/10.1158/1078-0432.22457417
Autor:
Julien Mazières, Gilles Favre, Julie Milia, Anne Casanova, Michèle Beau-Faller, Jacques Cadranel, Thomas Filleron, Valérie Lauwers-Cances, Emilie Bousquet, Isabelle Rouquette, Isabelle Raymond-Letron, Anne Pradines, Olivier Calvayrac
Purpose: A crucial event in lung adenocarcinoma progression is the switch from an aerogenous spread toward an infiltrating tumor. Loss of RhoB expression has been suggested to be critical for lung cancer invasion. Here, we tested RhoB expression as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e90913f977b67762a17e0f0224d510
https://doi.org/10.1158/1078-0432.c.6523574.v1
https://doi.org/10.1158/1078-0432.c.6523574.v1